MD School of Public Health, University of Chile, Av. Independencia 939, Santiago 8380000, Chile.
PhD Epidemiology Program, School of Public Health, University of Chile, Av. Independencia 939, Santiago 8380000, Chile; and Corresponding author. Email:
Sex Health. 2020 Dec;17(6):493-502. doi: 10.1071/SH20089.
Background Sexualised drug use has attracted interest due to the role it could play in increasing exposure to the transmission of HIV and other sexually transmissible infections. It also carries risks inherent to substance use and may influence psychosocial factors. This study characterised sexualised drug use among Latin America MSM Internet Survey (LAMIS) respondents in Chile, in order to identify aspects associated with the phenomenon.
LAMIS data were used to analyse: drug use (in any context, in sexual context and sexualised drug use), epidemiological aspects and psychosocial aspects. In addition, the associations between the sexualised drug use and these aspects were estimated.
The prevalence of sexualised drug use was 24% (n = 4945). The drugs most used in a sexual context (n = 3365) were cannabis, poppers and viagra. Cocaine, ecstasy/MDMA (3,4-Methylenedioxymethamphetamine) and ketamine use were reported in sexual encounters with multiple partners. Living with HIV (adjusted odds ratio (AOR) = 1.92), having had sex with three or more casual partners in the past year (AOR = 2.02) and having engaged in sex without a condom with three or more casual partners in this period (AOR = 1.61) were aspects associated with sexualised drug use. Less social integration (AOR = 0.76) and internalised homonegativity (AOR = 0.85) were aspects associated with a decrease of possibility of practising sexual drug use.
Sexualised drug use is an emerging phenomenon in Chile, whose complexity needs to be studied in all its dimensions to have a complete understanding of its effect on people's health.
本研究旨在对智利拉丁美洲男男性接触者互联网调查(LAMIS)的调查对象进行分析,以明确与性化药物使用相关的因素。
利用 LAMIS 数据,对以下方面进行分析:药物使用情况(无论是否与性有关、在性环境中以及性化药物使用)、流行病学方面和社会心理方面。此外,还对性化药物使用与这些方面之间的相关性进行了评估。
性化药物使用的总体流行率为 24%(n=4945)。在性环境中使用最多的药物是大麻、霹雳可卡因和伟哥。可卡因、摇头丸/MDMA(3,4-亚甲基二氧甲基苯丙胺)和氯胺酮在与多个性伴侣发生性行为时被使用。感染艾滋病毒(调整后比值比(AOR)=1.92)、过去一年与三个或更多偶然伴侣发生过性行为(AOR=2.02)以及在此期间与三个或更多偶然伴侣发生过未使用安全套的性行为(AOR=1.61),这些都是与性化药物使用相关的因素。社会融合程度较低(AOR=0.76)和内化的同性恋消极态度(AOR=0.85),与性化药物使用可能性降低有关。
性化药物使用是智利的一个新兴现象,需要从各个层面研究其复杂性,以便全面了解其对人们健康的影响。